|
Market Closed -
OTC Markets
22:32:22 16/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | 0.00% |
|
0.00% | -99.00% |
| Market Cap | 14.69K 13.34K 12.33K 11.14K 21.02K 1.38M 21.76K 148K 58.75K 740K 55.12K 53.95K 2.34M | P/E 2024 |
3.64x | P/E 2025 | -13x |
|---|---|---|---|---|---|
| Enterprise Value | 247K 224K 207K 187K 353K 23.16M 365K 2.49M 987K 12.43M 926K 906K 39.37M | EV / Sales 2024 |
3.14x | EV / Sales 2025 | 4.44x |
| Free-Float |
99.92% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 week | 0 | 0 | |
| 1 month | 0 | 0 | |
| Current year | 0 | 0 | |
| 1 year | 0 | 0 | |
| 3 years | 0 | 0 | |
| 5 years | 0 | 0 | |
| 10 years | 0 | 0 |
| Manager | Title | Age | Since |
|---|---|---|---|
H. Flippen
CEO | Chief Executive Officer | 54 | 22/11/2024 |
Fredrick Cutcher
CEO | Chief Executive Officer | 40 | 17/05/2023 |
Ed Capko
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Fredrick Cutcher
CHM | Chairman | 40 | 17/05/2023 |
H. Flippen
CHM | Chairman | 54 | 19/05/2025 |
William Norton
BRD | Director/Board Member | - | 04/06/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 5/28/24 A | Buy | Chairperson | 5,000,000 | 0.0340% | ||
| 5/23/24 A | Buy | Chairperson | 6,650,000 | 0.0453% | ||
| 3/31/21 A | Issuer sale | Chief Executive Officer | 810,000,000 | 5.4071% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | 0.00% | - | - | 14.69K | ||
| -0.82% | +1.40% | +40.13% | +143.17% | 1,286B | ||
| -1.12% | +0.16% | +41.57% | +88.24% | 688B | ||
| -0.16% | +0.43% | +25.88% | +113.01% | 521B | ||
| +1.14% | +4.87% | +43.06% | +71.97% | 386B | ||
| -2.23% | -2.89% | +55.57% | +41.64% | 364B | ||
| +1.27% | +2.01% | +30.01% | +62.35% | 302B | ||
| +0.37% | +0.75% | +3.71% | +39.09% | 287B | ||
| -0.72% | -0.63% | +35.30% | +71.87% | 252B | ||
| -0.30% | -1.03% | +35.05% | +124.88% | 208B | ||
| Average | -0.18% | +1.87% | +34.47% | +84.03% | 429B | |
| Weighted average by Cap. | -0.51% | +3.26% | +36.53% | +98.00% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.06M 961K 888K 802K 1.51M 99.31M 1.57M 10.68M 4.23M 53.29M 3.97M 3.88M 169M | 1.05M 950K 878K 793K 1.5M 98.18M 1.55M 10.56M 4.18M 52.69M 3.92M 3.84M 167M |
| Net income | 812K 738K 682K 616K 1.16M 76.25M 1.2M 8.2M 3.25M 40.92M 3.05M 2.98M 130M | -343K -311K -288K -260K -490K -32.18M -508K -3.46M -1.37M -17.27M -1.29M -1.26M -54.69M |
| Net Debt | 388K 352K 325K 294K 554K 36.39M 574K 3.91M 1.55M 19.53M 1.45M 1.42M 61.85M | 232K 211K 195K 176K 332K 21.78M 344K 2.34M 928K 11.69M 871K 852K 37.03M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/11/26 | $0.000001 | 0.00% | 13,240 |
| 13/11/26 | $0.000001 | 0.00% | 45,827 |
| 12/11/26 | $0.000001 | 0.00% | 262,000 |
| 10/11/26 | $0.000001 | 0.00% | 50,000 |
| 09/11/26 | $0.000001 | 0.00% | 103,000 |
- Stock Market
- Stocks
- GTLL Stock
Select your edition
All financial news and data tailored to specific country editions
















